Cargando…

A novel 9-gene signature for the prediction of postoperative recurrence in stage II/III colorectal cancer

Background: Individualized recurrence risk prediction in patients with stage II/III colorectal cancer (CRC) is crucial for making postoperative treatment decisions. However, there is still a lack of effective approaches for identifying patients with stage II and III CRC at a high risk of recurrence....

Descripción completa

Detalles Bibliográficos
Autores principales:	Xin, Cheng, Lai, Yi, Ji, Liqiang, Wang, Ye, Li, Shihao, Hao, Liqiang, Zhang, Wei, Meng, Ronggui, Xu, Jun, Hong, Yonggang, Lou, Zheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Genetics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9871489/ https://www.ncbi.nlm.nih.gov/pubmed/36704343 http://dx.doi.org/10.3389/fgene.2022.1097234

Ejemplares similares

Identification of a Novel Immune-Related CpG Methylation Signature to Predict Prognosis in Stage II/III Colorectal Cancer
por: Chen, Feng, et al.
Publicado: (2021)

A circRNA signature predicts postoperative recurrence in stage II/III colon cancer
por: Ju, Huai‐Qiang, et al.
Publicado: (2019)

Postoperative circulating tumor DNA as markers of recurrence risk in stages II to III colorectal cancer
por: Chen, Gong, et al.
Publicado: (2021)

The Ratio of CD86+/CD163+ Macrophages Predicts Postoperative Recurrence in Stage II-III Colorectal Cancer
por: Xu, Guozeng, et al.
Publicado: (2021)

Exploration of predictive biomarkers for postoperative recurrence of stage II/III colorectal cancer using genomic sequencing
por: Kishigami, Fumishi, et al.
Publicado: (2022)

Identification and Validation of a Six Immune-Related Genes Signature for Predicting Prognosis in Patients With Stage II Colorectal Cancer
por: Li, Xianzhe, et al.
Publicado: (2021)

A robust circular RNA-based prognostic signature for postoperative recurrence in stage II/III colon cancer
por: Ruan, Ji
Publicado: (2019)

CT-Based Radiomics Signature: A Potential Biomarker for Predicting Postoperative Recurrence Risk in Stage II Colorectal Cancer
por: Fan, Shuxuan, et al.
Publicado: (2021)

Diagnostic Accuracy of Elevated Serum Carcinoembryonic Antigen for Recurrence in Postoperative Stage II Colorectal Cancer Patients: Comparison With Stage III
por: Kim, Ho Seung, et al.
Publicado: (2013)

Identification of a chromatin regulator signature and potential prognostic ability for adrenocortical carcinoma
por: Li, Junwu, et al.
Publicado: (2022)

Risk factors for postoperative recurrence in patients with stage II colorectal cancer
por: Xiong, Zhi-Zhong, et al.
Publicado: (2023)

Identification of an Autophagy-Related Gene Signature for the Prediction of Prognosis in Early-Stage Colorectal Cancer
por: Lin, Xu-tao, et al.
Publicado: (2021)

Clinical Significance and Inflammatory Landscape of aNovel Recurrence-Associated Immune Signature in Stage II/III Colorectal Cancer
por: Liu, Zaoqu, et al.
Publicado: (2021)

Identification and characterization of ANO9 in stage II and III colorectal carcinoma
por: Li, Chunxiang, et al.
Publicado: (2015)

Methylated septin 9 gene is an important prognostic marker in stage II and stage III colorectal cancer for evaluating local recurrence or distant metastasis after surgery
por: Huang, Mingliang, et al.
Publicado: (2022)

Identification of Autophagy-Associated Biomarkers and Corresponding Regulatory Factors in the Progression of Colorectal Cancer
por: Zhang, Chunrui, et al.
Publicado: (2020)

An immune, stroma, and epithelial–mesenchymal transition‐related signature for predicting recurrence and chemotherapy benefit in stage II–III colorectal cancer
por: Cai, Du, et al.
Publicado: (2023)

A 12-immune cell signature to predict relapse and guide chemotherapy for stage II colorectal cancer
por: Tian, Xianglong, et al.
Publicado: (2020)

Maturation of tertiary lymphoid structures and recurrence of stage II and III colorectal cancer
por: Posch, Florian, et al.
Publicado: (2017)

ColoFinder: a prognostic 9-gene signature improves prognosis for 871 stage II and III colorectal cancer patients
por: Shi, Mingguang, et al.
Publicado: (2016)

A Combined RNA Signature Predicts Recurrence Risk of Stage I-IIIA Lung Squamous Cell Carcinoma
por: Sun, Li, et al.
Publicado: (2021)

Identification of a ferroptosis-related gene signature predicting recurrence in stage II/III colorectal cancer based on machine learning algorithms
por: Wang, Ze, et al.
Publicado: (2023)

A Robust Seven-Gene Signature Associated With Tumor Microenvironment to Predict Survival Outcomes of Patients With Stage III–IV Lung Adenocarcinoma
por: Zhao, Hao, et al.
Publicado: (2021)

Prognostic Factors for Post-Recurrence Survival in Stage II and III Colorectal Carcinoma Patients
por: Nikolic, Neda, et al.
Publicado: (2021)

Colorectal Cancer-Associated Microbiome Patterns and Signatures
por: Zhao, Lan, et al.
Publicado: (2021)

Identification of an Immune-Related Gene Signature to Improve Prognosis Prediction in Colorectal Cancer Patients
por: Dai, Siqi, et al.
Publicado: (2020)

Development and clinical validation of a novel six-gene signature for accurately predicting the recurrence risk of patients with stage II/III colorectal cancer
por: Liu, Zaoqu, et al.
Publicado: (2021)

A Novel Prognostic Model of Early-Stage Lung Adenocarcinoma Integrating Methylation and Immune Biomarkers
por: Ren, Jin, et al.
Publicado: (2021)

Circulating Methylated SEPT9 DNA Analyses to Predict Recurrence Risk and Adjuvant Chemotherapy Benefit in Stage II to III Colorectal Cancer
por: Yuan, Zhen, et al.
Publicado: (2022)

A novel prognostic prediction tool for postoperative recurrence in patients with stage II/III colon cancer
por: Ma, Jian, et al.
Publicado: (2019)

Identification of a Recurrence Gene Signature for Ovarian Cancer Prognosis by Integrating Single-Cell RNA Sequencing and Bulk Expression Datasets
por: Zhang, Yongjian, et al.
Publicado: (2022)

Impact of Postoperative Naples Prognostic Score to Predict Survival in Patients with Stage II–III Colorectal Cancer
por: Park, Su Hyeong, et al.
Publicado: (2023)

Optimal postoperative surveillance strategies for stage III colorectal cancer
por: Park, Min Young, et al.
Publicado: (2021)

Development and validation of a collagen signature to predict the prognosis of patients with stage II/III colorectal cancer
por: Dong, Shumin, et al.
Publicado: (2023)

Identification and validation of an inflammation-related lncRNAs signature for improving outcomes of patients in colorectal cancer
por: Huang, Mengjia, et al.
Publicado: (2022)

Comprehensive molecular characterizations of stage I–III lung adenocarcinoma with tumor spread through air spaces
por: Ye, Ronghao, et al.
Publicado: (2023)

Enhancer-associated regulatory network and gene signature based on transcriptome and methylation data to predict the survival of patients with lung adenocarcinoma
por: Huang, Shihao, et al.
Publicado: (2022)

High-throughput proteomics profiling-derived signature associated with chemotherapy response and survival for stage II/III colorectal cancer
por: Ye, Shu-Biao, et al.
Publicado: (2023)

A novel lactate metabolism-related signature predicts prognosis and tumor immune microenvironment of breast cancer
por: Zhang, Zhihao, et al.
Publicado: (2022)

Construction and validation of an aging-related gene signature predicting the prognosis of pancreatic cancer
por: Wang, Dengchuan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_jbqg383rirucp4ng8j88ap3ujd